The Essential Drugs List is a fundamental element in promoting rational drug use and controlling health care costs.
The Kenya Essential Drug List (KEDL) will be updated regularly by the National Pharmacy and Therapeutics Committee. The Director Medical of Services (Chairman) and the Chief Pharmacist (Secretary) will appoint the National Pharmacy and Therapeutics of 18 members representation from the following individuals and groups:
(1) Ministry of Health Headquarters and Medical Supplies Coordinating Unit
(2) Provincial Medical Officers of Health
(3) Medical practitioners and pharmacists representing Provincial Hospital Pharmacy and Therapeutics Committees
(4) Medical practitioners and pharmacists representing District Hospital Pharmacy and Therapeutics Committees
(5) Clinical and Pharmacy Departments of the public universities, including a clinical pharmacologist and clinical pharmacist
(6) Kenyatta National Hospital Pharmacy and Therapeutic Committee
(7) Mission and private health institutions
The KEDL will be updated regularly but not later than every two years by the National Pharmacy and Therapeutics Committee. The products in the list will be identified only by their generic names (INN - International Non-proprietary Name).
The criteria for selection of drugs in the KEDL are:
(1) Quality, safety, efficacy and cost
(2) Intended level of care at which drugs will be utilized
(3) Epidemiological profile
The KEDL will be the basis for the following activities:
• public education and information,
• public sector procurement, prescribing, and dispensing,
• medical education,
• in-service training programmes for health professionals,
• selective support for the local pharmaceutical industry,
• pricing policies, and
• control of drug donations.